Switching Patients with Non-Dialysis Chronic Kidney Disease from Oral Iron to Intravenous Ferric Carboxymaltose: Effects on Erythropoiesis-Stimulating Agent Requirements, Costs, Hemoglobin and Iron Status

Open Access

Peer-reviewed

Research Article

Jorge Eduardo Toblli ,

* E-mail: jorgetoblli@fibertel.com.ar

Affiliation Department of Nephrology, Hospital Alemán, Buenos Aires, Argentina
⨯
Federico Di Gennaro

Affiliation Department of Nephrology, Hospital Alemán, Buenos Aires, Argentina
⨯

Reader Comments (0)

Ferritin
Is the Subject Area "Ferritin" applicable to this article?

Thanks for your feedback.
Iron deficiency anemia
Is the Subject Area "Iron deficiency anemia" applicable to this article?

Thanks for your feedback.
Chronic kidney disease
Is the Subject Area "Chronic kidney disease" applicable to this article?

Thanks for your feedback.
Hemoglobin
Is the Subject Area "Hemoglobin" applicable to this article?

Thanks for your feedback.
Iron deficiency
Is the Subject Area "Iron deficiency" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Aminotransferases
Is the Subject Area "Aminotransferases" applicable to this article?

Thanks for your feedback.
Creatinine
Is the Subject Area "Creatinine" applicable to this article?

Thanks for your feedback.